Gray matter correlates of cognitive performance differ between relapsing-remitting and primary-progressive multiple sclerosis

Laura E. Jonkman, Diana M. Rosenthal, Maria Pia Sormani, Laura Miles, Joseph Herbert, Robert I. Grossman, Matilde Inglese

Research output: Contribution to journalArticlepeer-review

Abstract

Multiple Sclerosis (MS) is a chronic inflammatory/demyelinating and neurodegenerative disease of the central nervous system (CNS). Most patients experience a relapsing-remitting (RR) course, while about 15-20% of patients experience a primary progressive (PP) course. Cognitive impairment affects approximately 40-70% of all MS patients and differences in cognitive impairment between RR-MS and PP-MS have been found. We aimed to compare RR-MS and PP-MS patients in terms of cognitive performance, and to investigate the MRI correlates of cognitive impairment in the two groups using measures of brain volumes and cortical thickness. Fifty-seven patients (42 RR-MS, 15 PP-MS) and thirty-eight matched controls underwent neuropsychological (NP) testing and MRI. PP-MS patients scored lower than RR-MS patients on most of the NP tests in absence of any specific pattern. PP-MS patients showed significantly lower caudate volume. There was no significant difference in MRI correlates of cognitive impairment between the two groups except for a prevalent association with MRI measures of cortical GM injury in RR-MS patients and with MRI measures of subcortical GM injury in PP-MS patients. This suggests that although cognitive impairment results from several factors, cortical and subcortical GM injury may play a different role depending on the disease course.

Original languageEnglish (US)
Article number129380
JournalPloS one
Volume10
Issue number10
DOIs
StatePublished - Oct 20 2015

ASJC Scopus subject areas

  • General Biochemistry, Genetics and Molecular Biology
  • General Agricultural and Biological Sciences

Fingerprint

Dive into the research topics of 'Gray matter correlates of cognitive performance differ between relapsing-remitting and primary-progressive multiple sclerosis'. Together they form a unique fingerprint.

Cite this